Acalabrutinib monotherapy in patients with Waldenström macroglobulinemia: a single-arm, multicentre, phase 2 study - The Lancet Get link Facebook X Pinterest Email Other Apps December 23, 2019 Acalabrutinib monotherapy in patients with Waldenström macroglobulinemia: a single-arm, multicentre, phase 2 study The Lancet Get link Facebook X Pinterest Email Other Apps Comments
Comments
Post a Comment